Jianmin Pharmaceutical Group Co.,Ltd.

SSE:600976.SS

40.7 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 362.179523.234405.504325.421148.68692.63481.391.44165.06587118.9596.20282.53678.27668.50146.42215.5478.77113.54724.62431.20328.351
Depreciation & Amortization 41.17959.05738.82128.68420.69619.54619.89718.99716.74614.79514.41513.29613.3715.36915.87517.12915.59515.66217.90117.19612.1310.023
Deferred Income Tax 000.77-29.432-32.448-12.83-1.17-7.431-8.183-6.348000000000000
Stock Based Compensation 08.859.44310.271000000000000000000
Change In Working Capital -25.277-86.78-143.4896.32645.158.35711.705-43.54939.83-22.572-20.733-57.1068.796-165.37472.312-6.7958.141-48.21919.158-88.544-38.603-41.067
Accounts Receivables 140.302-252.666-302.9793.993-212.796-164.49333.736-73.467-111.138-47.043-20.45-253.253-1.964000000000
Inventory 95.64-92.82-140.299.747-93.99628.8026.561-10.012-34.554-13.086-1.856-17.573-13.366-23.624-51.86317.3791.38292.522-24.06-22.89517.554-7.338
Accounts Payables 0258.706299.0114.468384.391156.878-27.42247.361193.70543.906000000000000
Other Working Capital -261.21800.77-11.882-32.448-12.835.144-33.53674.384-9.485-18.877-39.53322.162-141.75124.176-24.16956.758-140.74143.217-65.649-56.157-33.729
Other Non Cash Items -143.816-235.971-95.183-82.086-88.994-46.087-49.303-31.693-7.801-30.773-9.402-7.034-6.528-3.814-6.6099.93220.82516.9025.56912.091-0.5976.88
Operating Cash Flow 234.265268.39215.865259.183125.53974.44963.59835.197113.8448.45103.22945.35898.174-75.543150.07966.693110.108-6.88356.175-34.6334.1334.188
Investing Activities:
Investments In Property Plant And Equipment -120.289-64.502-67.964-55.991-45.582-69.314-42.367-41.934-29.42-29.752-26.772-23.901-8.968-8.454-5.412-14.496-8.687-9.905-16.613-18.516-57.643-97.883
Acquisitions Net 021.8160.2431.1470.0630.0572.0350.1031.06615.38905.4130.6754.0810.4477.01845.3-9.64519.9520.17659.5930.272
Purchases Of Investments 0-31-41.445-1.147-239.236-5-40-60-47.811-40.40-7-3.45-4.647-1.881-0.03-148.553-20-0.3-73.594-2-0.366
Sales Maturities Of Investments 206.773107.541183.80236.30479.70726.77351.60551.79924.9822.75119.7393.2550.93322.3537.4829.0022.7481.0662.420.3231.4861.072
Other Investing Activites -333.389-214.357-217.83227.19140.2265.745-42.024-98.997140.25-33.403-8.158-122.31234.397-21.406-200.0810.11999.664.999-16.613-18.516-57.643-3.344
Investing Cash Flow -246.904-180.502-143.1967.504-164.82818.26-70.752-149.02989.065-65.414-15.191-144.54423.586-8.075-189.45271.612-9.532-33.486-11.156-90.127-56.207-100.25
Financing Activities:
Debt Repayment 65.352-7.702-22.5250000-21.93000-30305.7-8020-5-28.37534.8-40.658.878
Common Stock Issued 00038.3381.6600000000000000000
Common Stock Repurchased 000-38.338-1.6600000000000000000
Dividends Paid -187.718-156.201-123.341-58.607-30.68-31.264-31.165-19.744-34.04-62.005-61.892-59.6-67.536-48.604-21.691-8.378-13.743-5.189-7.222-9.546-29.031-5.513
Other Financing Activities 21.80978.207-43.6-6.998-10.182-0.2864.5342.181.254.65-16.4915.5001.31809.8850-5.231-0386.8540.1
Financing Cash Flow -100.557-85.696-189.441-50.483-42.522-31.55-26.63-17.564-54.77-7.355-78.382-44.1-97.536-18.604-15.991-88.37816.142-10.189-38.47625.254317.22353.465
Other Information:
Effect Of Forex Changes On Cash 000000-0-0000000-000-000-0-0
Net Change In Cash -113.196105.385-116.772216.204-81.81261.16-33.784-131.396148.135-24.329.656-143.28524.224-102.222-55.36549.927116.718-50.5576.542-99.505265.149-42.597
Cash At End Of Period 155.394268.59163.205278.36362.158143.9782.81116.594247.9999.854124.174114.518257.804233.58335.802391.167317.004200.286250.843244.301343.80678.658